<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang ASP</submitter><funding>European Research Council</funding><funding>Dutch Research Council (NWO)</funding><funding>The Netherlands Organisation for Health Research and Development Off-Road grant</funding><funding>ZonMw</funding><pagination>4631</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10397232</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>Plasmodium falciparum (Pf) parasite development in liver represents the initial step of the life-cycle in the human host after a Pf-infected mosquito bite. While an attractive stage for life-cycle interruption, understanding of parasite-hepatocyte interaction is inadequate due to limitations of existing in vitro models. We explore the suitability of hepatocyte organoids (HepOrgs) for Pf-development and show that these cells permitted parasite invasion, differentiation and maturation of different Pf strains. Single-cell messenger RNA sequencing (scRNAseq) of Pf-infected HepOrg cells has identified 80 Pf-transcripts upregulated on day 5 post-infection. Transcriptional profile changes are found involving distinct metabolic pathways in hepatocytes with Scavenger Receptor B1 (SR-B1) transcripts highly upregulated. A novel functional involvement in schizont maturation is confirmed in fresh primary hepatocytes. Thus, HepOrgs provide a strong foundation for a versatile in vitro model for Pf liver-stages accommodating basic biological studies and accelerated clinical development of novel tools for malaria control.</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Development of Plasmodium falciparum liver-stages in hepatocytes derived from human fetal liver organoid cultures.</pubmed_title><pmcid>PMC10397232</pmcid><funding_grant_id>04510012010050</funding_grant_id><funding_grant_id>VI.Veni.212.134</funding_grant_id><funding_grant_id>VI.Veni.192.171</funding_grant_id><funding_grant_id>016.Veni.171.015</funding_grant_id><funding_grant_id>016.166.140</funding_grant_id><funding_grant_id>101042738</funding_grant_id><pubmed_authors>Kretzschmar K</pubmed_authors><pubmed_authors>Boonekamp KE</pubmed_authors><pubmed_authors>Yang ASP</pubmed_authors><pubmed_authors>Clevers H</pubmed_authors><pubmed_authors>Hendriks D</pubmed_authors><pubmed_authors>Sauerwein RW</pubmed_authors><pubmed_authors>Dutta D</pubmed_authors><pubmed_authors>van Waardenburg Y</pubmed_authors><pubmed_authors>Chuva de Sousa Lopes SM</pubmed_authors><pubmed_authors>Hu H</pubmed_authors><pubmed_authors>Puschhof J</pubmed_authors><pubmed_authors>van Gemert GJ</pubmed_authors><pubmed_authors>de Wilt JHW</pubmed_authors><pubmed_authors>Bousema T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development of Plasmodium falciparum liver-stages in hepatocytes derived from human fetal liver organoid cultures.</name><description>Plasmodium falciparum (Pf) parasite development in liver represents the initial step of the life-cycle in the human host after a Pf-infected mosquito bite. While an attractive stage for life-cycle interruption, understanding of parasite-hepatocyte interaction is inadequate due to limitations of existing in vitro models. We explore the suitability of hepatocyte organoids (HepOrgs) for Pf-development and show that these cells permitted parasite invasion, differentiation and maturation of different Pf strains. Single-cell messenger RNA sequencing (scRNAseq) of Pf-infected HepOrg cells has identified 80 Pf-transcripts upregulated on day 5 post-infection. Transcriptional profile changes are found involving distinct metabolic pathways in hepatocytes with Scavenger Receptor B1 (SR-B1) transcripts highly upregulated. A novel functional involvement in schizont maturation is confirmed in fresh primary hepatocytes. Thus, HepOrgs provide a strong foundation for a versatile in vitro model for Pf liver-stages accommodating basic biological studies and accelerated clinical development of novel tools for malaria control.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Aug</publication><modification>2025-04-18T17:01:13.57Z</modification><creation>2025-04-07T04:31:15.244Z</creation></dates><accession>S-EPMC10397232</accession><cross_references><pubmed>37532704</pubmed><doi>10.1038/s41467-023-40298-7</doi></cross_references></HashMap>